All
Keeping Best Ergonomics Practices at the Forefront in Mohs Surgery
An ACMS poster session indicates Mohs micrographic surgeons and histology technicians are at high risk of developing musculoskeletal injuries from their day-to-day tasks.
Getting to Know BC Educators: Biologic Coordinators Services
The inaugural ACBC Texas Round Up 2023 meeting kicks off this week to further promote biologic access training.
Creating a Telehealth Experience For Postoperative Appointments
Laura Rezac, MD and her colleagues evaluated a teledermatology postoperative follow-up model after Mohs Micrographic surgery.
The Importance of Collaboration Between Mohs Surgeons and Urologists
Caleb Kovell, MD and Junqian Zhang, MD demonstrated how teaming up increases the likelihood for positive patient outcomes in Mohs cases on the genitalia and perianal region.
POLL: Would You Consider a Telehealth Option For Postoperative Appointments?
The question was a conversation starter after an ACMS clinical abstract presentation.
Addressing Disparities in Atopic Dermatitis Through Teledermatology
Adam Friedman, MD, FAAD, discusses his RAD 2023 session, "Using Teledermatology to Reduce Disparities in Atopic Dermatitis."
Making AI Work in Mohs Micrographic Surgery Workflow
An ACMS poster session delves into the role artificial intelligence can play in the treatment of basal cell carcinoma.
POLL: Do You Think AI Technology Can Enhance the Mohs Surgery Workflow?
A poster session and ACMS keynote speaker Anant Madabhushi, MS, PhD, both delve into the use of AI in Mohs surgery.
Mohs for the Nose: Reconstruction Session Sneak Peek With Anna Bar, MD, FACMS
Bar will share insight on foldover interpolated flaps for full thickness of nasal defects.
Looking Ahead to the 2023 ACMS Meeting
The ACMS president and scientific program chair share opportunities to discover innovations in Mohs surgery during this weekend’s meeting.
Plan Your Trip: Explore the Emerald City
If you are attending the 2023 ACMS Meeting, check out these local attractions to soak up the best of Seattle between sessions.
SLIDESHOW: Recognizing National Skin Cancer and Melanoma Awareness Month
May is National Skin Cancer and Melanoma Awareness Month. We have skin cancer at the forefront of our coverage this month. Here is a recap of the latest news about skin cancer research, studies, and more.
Rad Quotes From RAD 2023
Experts in the field share why they enjoyed the 5th Annual Revolutionizing Atopic Dermatitis Conference and why it is unique.
2023 Revolutionizing Atopic Dermatitis Recap
Catch up on all coverage from Revolutionizing Atopic Dermatitis.
Ruxolitinib Cream Provides Substantial, Sustained Itch Relief in AD Patients
A single-site study involving an adult cohort with atopic dermatitis saw significant itch improvement.
Discussing Disparities in AD With Andrew Alexis, MD, MPH
Alexis discusses his Revolutionizing Atopic Dermatitis session, “Disparities in the Care of Atopic Dermatitis in the United States.”
POLL: How Many Dermatology Conferences Have You Attended So Far in 2023?
Click here to answer this week's poll.
Assessing Itch Severity and Skin Clearance Supports Shared Decision Making
New data from RAD 2023 revealed the results of assessing the independent and combined effects of itch and skin severity on patient-reported symptoms and QoL.
FDA Grants Breakthrough Therapy Designation For Spesolimab
The intention is to expedite the development and review of the drug helping adults with generalized pustular psoriasis.
Digital Educational Intervention Increases Awareness Among Hispanic Patients With AD
The study examined the impact of an educational intervention on the population with the highest prevalence of the disease.
Dupilumab Efficacious in Pediatric Patients as Young as 6 Months
The drug was both safe and effective in patients ages 6 months to 5 years.
Crucial Conversations Are Needed to Address Racism in Medicine
Candrice Heath, MD, FAAP, FAAD, reviewed the important conversations dermatologists need to have to understand how racism affects SOC patients with atopic dermatitis at RAD 2023.
POLL: Are You Attending the 2023 Annual Meeting of the American College of Mohs Surgery in Seattle?
Revolutionizing Atopic Dermatitis Recap: Day 3
Catch up on coverage from the third day of Revolutionizing Atopic Dermatitis.
Abrocitinib Has Acceptable Long-Term Safety Profile in Adolescents with AD
Researchers determined there were no unique safety concerns in the study, which spanned 1000 patient years.
Late-Breaking Data: Dupilumab Significantly Improves Signs, Symptoms, and QoL in Patients With Hand & Foot Dermatitis
Jonathan Silverberg, MD, PhD, MPH, presented late-breaking dupilumab data at RAD 2023.
New Drugs in 2023, Patient Satisfaction, and RAD Takeaways With Melinda Gooderham, MSc, MD, FRCPC
Gooderham’s sessions covered upcoming AD drug approvals, patient satisfaction and QoL improvement, and RAD 2023 takeaways.
Sara’s Skin Security: Arm Them With Knowledge
Discussing photoprotection with patients is crucial as “Melanoma May" kicks off this month.
Crisaborole Ointment Leads to Significant, Consistent Improvements in AD
In a cohort of Chinese and Japanese pediatric patients, researchers deemed the topical treatment both safe and effective.
Upadacitinib, Long-Term Control, and Tapinarof, Oh My!
Raj Chovatiya, MD, PhD, discusses highlights from his sessions at RAD 2023 on best practices for AD management.